Pramiracetam vs phenylpiracetam is a comparison between two synthetic racetam nootropics. They are often discussed by more advanced nootropic users seeking stronger memory, focus, mental energy or cognitive performance support.
Interest in cognitive enhancers is widespread. In a national AARP survey of U.S. adults age 50 and older, about 1 in 5 adults reported taking supplements specifically to support brain health, memory, attention, or focus.
That demand helps explain why some people look beyond ordinary nootropics toward racetam compounds—even though racetams are somewhat controversial. Pramiracetam is usually positioned as the more memory-focused racetam, while phenylpiracetam is known for stronger stimulation and physical-performance associations.
In this article, we compare how they work, what the research actually supports, how their risks differ and why neither should be treated like a normal nutritional supplement. Let's get to it!
Key Takeaways
- Pramiracetam and phenylpiracetam are synthetic racetams, not ordinary dietary supplements.
- Pramiracetam is usually taken for memory formation, long-term memory retention and support for neurotransmitter acetylcholine.
- Phenylpiracetam is usually discussed for stimulation, mental energy, physical performance and recovery support after a brain injury.
- Both compounds have cloudy U.S. status in terms of legality and regulation, and cannot be purchased like standard dietary supplements.
- Most clinical trials on these racetams are in various preclinical stages, animal models or on people with cognitive deficits, stroke, brain injury or memory problems—not healthy adults who are simply looking for a "brain boost."
- Legal nutritional nootropics like those in Mind Lab Pro offer a safer, more sensible path for supporting memory, focus, mental clarity and overall brain function.
Disclaimer
This article is for educational purposes only and is not medical advice. Pramiracetam and phenylpiracetam are synthetic racetam compounds; more like investigational drugs than ordinary dietary supplements. They are not intended to diagnose, treat, cure or prevent attention deficit hyperactivity disorder (ADHD), dementia, traumatic brain injury, stroke, Alzheimer’s disease patients (and other neurodegenerative diseases), depression, cognitive impairment, age-related cognitive decline, various cognitive disabilities, CNS disorders or any other medical condition. Speak with a qualified clinician before considering any unapproved nootropic, especially if you take medication, compete in tested sport, have a neurological or psychiatric condition, or are pregnant or breastfeeding.
Important Medical and Legal Context
Racetams are often discussed online as “smart drugs,” but that framing can be misleading. The FDA has stated in a warning letter that products including pramiracetam and phenylpiracetam are not dietary supplements or conventional foods when marketed for cognitive effects, and phenylpiracetam is banned in sport by the World Anti-Doping Agency. In other words, these compounds belong in a higher-risk category than vitamins, herbs, amino acids or mainstream nootropic supplements.(2,3,4)
What Are Pramiracetam and Phenylpiracetam?
Pramiracetam is a synthetic racetam developed from piracetam, the original racetam compound. It is best known for its potential role in memory formation, long-term retention of memories and anti-amnesia effects. It has been studied in early human research involving cognitive problems after head injury, oxygen deprivation, induced amnesia and age-related neurological issues.
Phenylpiracetam is another piracetam-derived racetam. Its key structural difference is the addition of a phenyl group, which appears to change how it behaves compared with piracetam. Phenylpiracetam is generally described as more stimulating than pramiracetam and has been studied in contexts such as stroke rehabilitation, organic brain lesions, fatigue-like states and neurological recovery.(4)
Racetams are synthetic nootropic compounds that share a similar structure. They are often grouped as nootropic drugs because of their proposed effects to sharpen memory, learning, brain function and cognitive performance; also because in other parts of the world they have been used as prescribed medications by doctors and described as such in scientific literature.
Racetams are not one uniform category. Some are more neurotransmitter-related, some more stimulating, and some have very little human evidence for cognitive enhancement.
Historically, racetams have mixed pharmaceutical and nootropic clinical uses. Piracetam originated in Europe. Phenylpiracetam has a stronger Russian and Soviet-era history. Pramiracetam was developed as a pharmaceutical-style memory compound, including for mild cognitive impairments related to age. Today, both are discussed by advanced nootropic users, but their status as “supplements” remains questionable. Our primary objective in this article is to compare and contrast these two racetams; we are not recommending either one.
How Do Pramiracetam and Phenylpiracetam Work?
Science does not yet understand the exact mechanisms of pramiracetam and phenylpiracetam. Most explanations come from animal studies, pharmacology research and indirect human findings.
Pramiracetam: Choline and Memory Signaling
Pramiracetam is most often linked to cholinergic pathways, meaning brain systems related to choline and acetylcholine.
Acetylcholine is a neurotransmitter involved in memory formation, attention and learning. Pramiracetam has been reported to influence choline uptake, especially in brain areas involved in memory.
This does not mean pramiracetam simply “raises acetylcholine” or works like a choline supplement. Its effects appear more complicated than that, and there is no strong evidence showing it may enhance memory in healthy adults.
Phenylpiracetam: Stimulation, Dopamine and Performance
Phenylpiracetam is usually described as more stimulating for cognitive function. Its structure may help explain why users and researchers have associated it with wakefulness, physical performance, motivation and mental energy.
The major focus of research on Phenylpiracetam suggests that its activity may involve dopamine-related pathways, though much of this work is preclinical rather than definitive human performance evidence.(4)
This stimulant-like profile is part of phenylpiracetam’s appeal—but also part of its risk. Stimulation may increase problems related to sleep disruption, jitters, blood pressure, anxiety, tolerance, misuse and drug-testing restrictions.
Discover how nootropic L-Theanine helps with caffeine jitters.
Did you know? Phenylpiracetam is listed as banned in sport because of its reported stimulant-like and performance-related properties, making it especially risky for competitive athletes subject to drug testing.
Pramiracetam and Phenylpiracetam Research: What Do Studies Suggest?
The research picture is uneven. Both compounds have clinical or preclinical evidence that may be relevant to cognition, and both can cross the blood-brain barrier to reach the brain. But the strongest findings generally come from impaired or clinical populations rather than healthy nootropic users.
Pramiracetam and Memory After Brain Injury
In a small placebo-controlled study, young men with memory and cognitive problems after head injury or oxygen deprivation received pramiracetam at 400 mg three times daily for 18 months. Researchers reported improvements on memory measures during treatment, with some effects lingering after treatment ended. This is one of the more relevant human studies for pramiracetam's potential clinical applications, but it involved only four patients with serious cognitive problems, so it cannot be assumed it will help healthy adults seeking memory enhancement.(5)
Pramiracetam and Induced Amnesia
Another placebo-controlled study tested whether pramiracetam could reduce scopolamine-induced memory impairment in healthy male volunteers. Scopolamine is a drug that disrupts cholinergic signaling in the central nervous system and can impair memory. Repeated pramiracetam use appeared to reduce impairment on some memory tests, while short-term dosing was less convincing. This supports a possible anti-amnesic or cholinergic effect, but it does not prove that pramiracetam improves normal memory above baseline.(6)
Pramiracetam and Alzheimer’s Disease
A controlled trial in people with probable Alzheimer’s disease found little reason to expect meaningful symptomatic benefit from pramiracetam at doses up to 4,000 mg daily. Some early responses did not hold up when tested more carefully. This is a useful reminder that preliminary cognitive signals do not always translate into real-world effectiveness.(7)
Phenylpiracetam and Stroke Rehabilitation
Phenylpiracetam has been studied more often in Russian clinical contexts. In one study involving patients with ischemic stroke, Phenylpiracetam was used as part of rehabilitation. Researchers reported improvements in rehab-related outcomes. However, because this research took place in a clinical recovery context and involved complex treatment, it should not be interpreted as proof that phenylpiracetam enhances cognition in healthy adults.(3)
Phenylpiracetam and Preclinical Cognitive Effects
Animal research comparing R- and S-enantiomers of Phenylpiracetam suggests that the R-isomer may be more active in behavioral tests related to stimulation and cognition. This supports the idea that phenylpiracetam’s effects are not identical to piracetam, but animal findings cannot establish safety or clinical efficacy for healthy human users.(4)
Pramiracetam vs Phenylpiracetam: Key Differences
Both compounds belong to the racetam family, but they are used and discussed for different reasons.
Memory vs Mental Energy
Pramiracetam is more strongly associated with memory. Its reputation is built around cholinergic activity and hippocampal memory pathways.
Phenylpiracetam is more strongly associated with stimulation, mental energy and physical performance. It is the more “activating” of the two.
Clinical Research Context
Pramiracetam research is most relevant to memory problems after head injury, oxygen deprivation and experimentally induced amnesia. Phenylpiracetam research is more often connected to stroke recovery, brain degeneration and neurological rehab.
Safety and Tolerability
Pramiracetam may carry risks typical of unapproved racetams, including unknown long-term safety, limited modern clinical data, uncertain product quality and possible interactions with medications or cholinergic compounds.
Phenylpiracetam may add more stimulant-like concerns, including insomnia, agitation, increased heart rate or blood pressure, anxiety, tolerance and drug-testing issues. Its performance-related reputation makes it especially unsuitable for athletes in tested sports.
Which Is Better?
For memory-focused research, pramiracetam has the clearer human evidence trail, although it is still weak and mostly limited to impaired populations. For stimulation and mental energy, phenylpiracetam is the stronger candidate conceptually, but also carries more stimulant-like risk and a bigger sports-compliance problem.
For most readers, the practical answer is that neither is an ideal starting point. The evidence is too limited, the legal status is too cloudy and the product-quality concerns are too high.
*For more background on racetam nootropics, you may also want to check out our guides on pramiracetam, oxiracetam and fasoracetam.
Dosage, Timing and How Long They Take
There is no FDA-approved or officially recommended dosage for pramiracetam or phenylpiracetam as nootropics to improve cognitive function. Any dose mentioned here reflects research or historical use only, not a self-use recommendation.
Pramiracetam human studies have often used a total of 1,200 mg daily, such as 400 mg three times daily or 600 mg twice daily. Research and source summaries suggest that effects may depend on repeated use rather than one acute dose, especially for memory-related outcomes.(5,6)
Phenylpiracetam is often described in source summaries as being used at much lower amounts than pramiracetam, commonly 100–200 mg per serving, sometimes repeated during the day. Because phenylpiracetam is more stimulating, timing would theoretically matter more for sleep and overstimulation concerns. Again, these are not recommendations.(2)
Side Effects, Safety and Who Should Be Careful
The biggest safety issue with both compounds is not just adverse effects. It is the combination of limited modern human safety data, unapproved status, inconsistent sourcing and unclear product quality.
People should be especially cautious if they have cardiovascular issues, blood pressure concerns, anxiety, bipolar disorder, seizure history, sleep problems, liver or kidney disease, neurological conditions, psychiatric conditions, or if they take prescription medications. Pregnant and breastfeeding women should avoid unapproved nootropic drugs unless specifically directed by a clinician.
Phenylpiracetam deserves extra caution for athletes and anyone subject to drug testing because it is banned in sport. Its stimulant-like profile may also make it more likely than pramiracetam to disrupt sleep or increase agitation. Read about safe and legal nootropics for athletes.
A 2021 analysis of cognitive-enhancement supplements found that some over-the-counter products contained unapproved pharmaceutical drugs, highlighting why gray-market “nootropic” products can be difficult for consumers to evaluate reliably.(8)
Can You Take Pramiracetam or Phenylpiracetam Every Day?
There is not enough evidence to say that daily use is safe or appropriate for healthy people. Some studies used repeated dosing over weeks or months, but those studies involved specific clinical or experimental contexts—not ordinary consumer nootropic use.
Daily phenylpiracetam use is especially questionable because of its stimulant-like character, possible tolerance concerns and sports-banned status. Daily pramiracetam use also lacks strong modern safety data.
Stacking and Combinations
Advanced users often discuss racetams with choline donors such as citicoline or alpha-GPC because racetams are frequently connected to acetylcholine pathways. However, there is no strong clinical evidence proving that a pramiracetam-choline or phenylpiracetam-choline stack is necessary, effective or safe for healthy people.
Combining racetams with stimulants, ADHD medication, antidepressants, sleep aids or other psychoactive substances increases uncertainty. Because phenylpiracetam may be activating, stacking it with caffeine or stimulant compounds may raise the risk of jitteriness, insomnia, anxiety or blood pressure effects.
Mind Lab Pro®: A Legal Nootropic Stack for Memory, Focus and Mental Clarity
Pramiracetam and phenylpiracetam may be appealing for people looking for sharper memory, faster thinking, better focus and more mental energy. But because they are synthetic racetam drugs with cloudy legal status and limited evidence in healthy adults, they are not a clean fit for most people.
Mind Lab Pro offers a different approach. It is a legal, caffeine-free, vegan-friendly nootropic formula built around nutritional compounds, herbs, amino acids, vitamins and mushroom extracts. It does not copy racetam pharmacology. Instead, it supports overlapping brain-performance goals and cognitive abilities through multiple pathways such as acetylcholine synthesis, brain-cell membrane support, stress resilience, cerebral blood flow, brain energy, antioxidant defenses and more. Read about how Mind Lab Pro works.
Mind Lab Pro includes:
- Cognizin® Citicoline — 250 mg: supports acetylcholine synthesis, phospholipid production, attention and brain energy.
- Phosphatidylserine (PS) — 100 mg: supports brain-cell membranes, memory and neuronal signaling.
- Bacopa Monnieri — 150 mg: standardized full-spectrum extract for memory and learning support.
- Organic Lion’s Mane Mushroom — 500 mg: supports neurotrophic and brain-health pathways.
- Rhodiola Rosea — 50 mg: supports stress resilience and mental performance under pressure.
- N-Acetyl L-Tyrosine — 175 mg: supplies a precursor for dopamine and norepinephrine.
- L-Theanine — 100 mg: supports calm focus and relaxed alertness.
- Maritime Pine Bark Extract — 75 mg: supports antioxidant defense and healthy circulation.
- Vitamin B6 — 2.5 mg: supports neurotransmitter synthesis and brain-energy metabolism.
- Vitamin B9 — 100 mcg: supports methylation and healthy brain chemistry.
- Vitamin B12 — 7.5 mcg: supports nervous-system health and energy metabolism.
Citicoline has the clearest connection to racetam-related cholinergic goals because it supports choline availability and acetylcholine synthesis. Discover more about citicoline as a nootropic.
Bacopa supports memory and learning, while Lion’s Mane supports neurotrophic brain-health pathways and phosphatidylserine supports healthy brain-cell membranes. Find out more about Bacopa Monnieri and read more about Lion’s Mane Mushroom.
Mind Lab Pro has also been studied in humans.
- In a double-blind, placebo-controlled study, adults taking Mind Lab Pro for 30 days improved on information-processing measures including simple reaction time, choice reaction time and anticipation versus control group.(9)
- In a separate double-blind, placebo-controlled study, participants improved test performance across several memory measures, including auditory memory, visual memory, working memory, immediate recall and delayed recall.(10)
- A third study using EEG during perceptual decision-making reported brain-network changes suggesting enhanced communication and coordination between brain regions after supplementation.(11)
Read more details on Mind Lab Pro studies.
Mind Lab Pro is not a racetam, not a stimulant drug and not intended to treat cognitive disorders or replace medical care. It is a safer, legal nutritional option for healthy adults who want support for memory, focus, mental clarity, stress resilience and overall cognitive performance.
Frequently Asked Questions
What is the main difference between pramiracetam and phenylpiracetam?
Pramiracetam is usually discussed for memory formation and cholinergic activity. Phenylpiracetam is usually discussed for stimulation, mental energy, physical performance and recovery after organic brain injury.
Is pramiracetam stronger than phenylpiracetam?
Not exactly. Pramiracetam may be more memory-focused, while phenylpiracetam is generally more stimulating. “Stronger” depends on the goal, and neither has strong evidence for healthy cognitive enhancement.
Is phenylpiracetam a stimulant?
Phenylpiracetam is often described as having psychostimulatory properties. That does not make it equivalent to prescription stimulants, but it does mean it carries more activating and drug-testing concerns than many other racetams.
Are pramiracetam and phenylpiracetam legal dietary supplements?
No. The FDA has stated that pramiracetam and phenylpiracetam products are not dietary supplements or conventional foods when marketed for cognitive effects. Their legal status is cloudy and higher-risk than ordinary supplement ingredients.
Which is better for memory?
Evidence based clinical investigations suggest Pramiracetam has the clearer memory-focused research trail, especially in small studies involving brain injury, oxygen deprivation and induced amnesia. But there are no convincing clinical outcomes that it reliably improves memory in healthy adults.
Which is better for focus and mental energy?
Phenylpiracetam is more associated with stimulation, mental energy and physical performance. However, that profile also brings greater concerns around sleep, agitation, blood pressure, tolerance and banned-substance status in sport.
Can I stack racetams with choline?
Some users combine racetams with choline donors, but strong clinical evidence is lacking. Combining unapproved nootropics with other cognitive compounds, stimulants or medications can increase uncertainty and safety risks.
Summary
Pramiracetam and phenylpiracetam are both synthetic racetam nootropics, but they are not interchangeable. Pramiracetam is more closely associated with memory formation, anti-amnesic effects and cholinergic pathways. Phenylpiracetam is more associated with stimulation, mental energy, physical performance and neurological recovery research.
The strongest evidence for both compounds comes from clinical or impaired populations, not healthy adults looking for enhanced cognitive performance. Pramiracetam has small studies involving memory problems after brain injury or induced amnesia. Phenylpiracetam has research in stroke rehabilitation and neurological contexts. Neither has a strong modern evidence base proving meaningful benefits for healthy nootropic users.
The bigger issue is risk. Both compounds have cloudy legal status: they are really investigative drugs with limited safety data and quality-control concerns. Phenylpiracetam also has stimulant-like properties and is banned in sport.
For advanced nootropic users, pramiracetam vs phenylpiracetam is an interesting comparison in racetam pharmacology. For most readers, however, legal nutritional nootropics offer a more practical path for supporting memory, focus, mental clarity and brain health without relying on unapproved synthetic drug compounds.
References
- Council for Responsible Nutrition. (2022). Supplements for brain health. Council for Responsible Nutrition. Link
- U.S. Food and Drug Administration. (2019). Peak Nootropics LLC aka Advanced Nootropics: Warning letter 557887. U.S. Food and Drug Administration. Link
- Koval’chuk, V. V. (2010). Efficacy of phenotropil in the rehabilitation of stroke patients. Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova, 110(12 Pt 2), 26–30. Link
- Zvejniece, L., Vavers, E., Svalbe, B., Veinberg, G., Rizhanova, K., Liepins, V., Kalvinsh, I., & Dambrova, M. (2011). Investigation into stereoselective pharmacological activity of phenotropil. Basic & Clinical Pharmacology & Toxicology, 109(5), 407–412. Link
- McLean, A., Cardenas, D. D., Burgess, D., & Gamzu, E. (1991). Placebo-controlled study of pramiracetam in young males with memory and cognitive problems resulting from head injury and anoxia. Brain Injury, 5(4), 375–380. Link
- Mauri, M., Sinforiani, E., Bono, G., Vignati, F., Bersani, G., & Nappi, G. (1994). Pramiracetam effects on scopolamine-induced amnesia in healthy volunteers. Arzneimittelforschung, 44(9), 1029–1032. Link
- Claus, J. J., Mohr, E., Chase, T. N., & Fedio, P. (1991). Nootropic drugs in Alzheimer’s disease: Symptomatic treatment with pramiracetam. Neurology, 41(4), 570–574. Link
- Cohen, P. A., Zakharevich, I., & Gerona, R. (2021). Five unapproved drugs found in cognitive enhancement supplements. Neurology: Clinical Practice, 11(3), e303–e307. Link
- Utley, A., Gonzalez, Y., & Imboden, C. A. (2023). The efficacy of a nootropic supplement on information processing in adults: A double blind, placebo controlled study. Biomedical Journal of Scientific & Technical Research, 49(1). Link
- Abbott-Imboden, C., Gonzalez, Y., & Utley, A. (2023). Efficacy of the nootropic supplement Mind Lab Pro on memory in adults: Double blind, placebo-controlled study. Human Psychopharmacology: Clinical and Experimental, 38(5), e2872. Link
- O’Reilly, D., Bolam, J., Delis, I., & Utley, A. (2025). Neural mechanisms of cognitive enhancement with a nootropic supplement. Brain Sciences, 15(3), 226. Link